510(k) Report

FDA applicant

Oncospace, Inc.

Baltimore, MD3 decisions2021–20250 recalls

FDA records 3 decisions for Oncospace, Inc. (Baltimore, MD) from 2021 to 2025: 3 510(k) clearances. All are in product code MUJ (System, Planning, Radiation Therapy Treatment). Since 2016 its 510(k)s took a median of 211 days from receipt to decision, against 140 for FDA’s reviews in the same codes and years. Its devices cite 3 predicates, 2 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, radiology panel, where it files most

How often FDA has decided Oncospace, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2021: 12023: 12025: 1
2021high 1 (2021) · low 0 (2022)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2021.

FIG. 1 — Oncospace, Inc. by year, 2021–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Oncospace, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Which product codes does it file in?

  • MUJSystem, Planning, Radiation Therapy Treatment3decisions

How long do its 510(k) reviews take?

Since 2016, its 3 510(k)s took a median of 211 days from FDA’s receipt to its decision. For 510(k)s in the same product codes and years, FDA’s median was 140 days; 1 of its 3 were faster than that.

Whose devices does it build on?

Its devices cite 3 predicates; 2 are its own earlier devices. The firms it cites most:

Who builds on its devices?

Later devices cite its devices 4 times; 2 of those are its own. The firms that cite it most:

Which of its devices are cited most?

Its devices that later submissions most often claim equivalence to.

  • K222803OncospaceOncospace, Inc. · 20233cite it
  • K202284OncospaceOncospace, Inc. · 20211cites it

What has FDA decided for it lately?

  • K242748OncospaceOncospace, Inc. · 2025
  • K222803OncospaceOncospace, Inc. · 2023
  • K202284OncospaceOncospace, Inc. · 2021

All 3 as Oncospace, Inc. →